Moderna, Searching for a Rebound, to Seek Approval of mRNA Flu Shot

Moderna Announces Global Regulatory Submissions for Its Investigational Seasonal Influenza Vaccine

Moderna has filed for marketing authorization in the U.S., EU, Canada and Australia for mRNA-1010

Moderna, searching for a rebound, to seek approval of mRNA flu shot

The company submitted an application for a seasonal flu vaccine it believes to be a key growth driver in the years ahead.

Moderna Seeks Regulatory Approval for mRNA Seasonal Flu Vaccine

Moderna has officially submitted applications to regulators in the U.S., Europe, Canada, and Australia for its seasonal influenza vaccine, mRNA-1010. Targetting adults aged 50 and older, the vaccine utilizes the same messenger RNA technology found in the company’s COVID-19 and RSV shots. Clinical trials demonstrated that mRNA-1010 reduced the risk of flu illness by 27% compared to traditional vaccines, with a safety profile consisting of mostly …

Moderna Submits Application for mRNA-Based Seasonal Flu Vaccine Approval

Moderna has officially submitted an application seeking […] The post Moderna Submits Application for mRNA-Based Seasonal Flu Vaccine Approval first appeared on GeneOnline News. The post Moderna Submits Application for mRNA-Based Seasonal Flu Vaccine Approval appeared first on GeneOnline News.

Moderna seeks flu vaccine approvals; Neumora Alzheimer's data

Plus, news about Incyte's Monjuvi: 😷 Moderna submits flu vaccine to global regulators: The company said Monday it filed approval applications to regulators in the US, Europe ...